BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE
申请人:GO Mei Lin
公开号:US20130035364A1
公开(公告)日:2013-02-07
Compounds of general formula I:
wherein
R
1a
, R
1b
, R
2
, R
3a
, R
3b
and X are as defined herein are tyrosine kinase inhibitors and are useful for the treatment of various diseases and conditions, for example cancer.
Highly enantio- and diastereoselective construction of spirocyclic oxindoles via a palladium-catalyzed decarboxylative asymmetric [4 + 2] annulation strategy
A palladium-catalyzed decarboxylative asymmetric [4 + 2] annulation of methyleneindolinones with a zwitterionic oxo-1,4-dipole intermediate was successfully developed to access spirocyclic oxindoles bearing two vicinal stereocenters in good yields with high diastereoselectivities and enantioselectivities. This strategy features a broad substrate scope (28 examples), allowing for efficient scale-up
USE OF NEUROPROTECTIVE 3-SUBSTITUTED INDOLONE COMPOSITIONS
申请人:D'Mello Santosh R.
公开号:US20090264494A1
公开(公告)日:2009-10-22
The present invention include providing a therapeutically effective amount of a 3-substituted indolin-2-one compositions to protect against neurodegeneration including diseases such as Alzheimer's disease, Parkinson's disease, or Huntington's disease, and conditions such as ischemic stroke
USE OF NOVEL NEUROPROTECTIVE 3-SUBSTITUTED INDOLONE COMPOSITIONS
申请人:D'Mello Santosh R.
公开号:US20100298376A1
公开(公告)日:2010-11-25
The present invention provides compositions and methods of synthesizing optionally substituted 3-substituted indolin-2-ones and methods to employ the resultant compounds to protect against neurodegeneration including diseases such as Alzheimer's disease, Parkinson's disease, or Huntington's disease, and conditions such as ischemic stroke.